secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0000950170-24-078795
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics stockholders elect three Class III directors and ratify KPMG as auditor
--------------------------------------------------------------------------------

- Nicoletta Loggia (7.18M for), Christopher Martell (6.99M for), Diem Nguyen (7.02M for) elected as Class III directors.
- KPMG LLP ratified as independent auditor for fiscal 2024 with 14.62M for, 98.9K against, 42.9K abstain.
- Meeting held June 26, 2024; record date May 15, 2024; 29.76M shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024078795/0000950170-24-078795-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024078795/cadl-20240626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-078795

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer